Great presentation by @sandrapdangelo on T-cell therapies in #sarcoma. TCRs clearly work for cancer-testis antigens in select patients and interesting data on TILs to be presented at #ESMO2026 on monday. However, patient selection still restricts who is eligible - target expression, HLA subtype…and geography! Afami-cell only approved by FDA, no other agent.

@myESMO @ctosociety @pawel_sobczuk